FindTrial
Sign In

China Aortic Valve tRanscatheter Replacement registrY

China Aortic Valve tRanscatheter Replacement registrY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038526
Enrollment
Unknown
Registered
2020-09-23
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic stenosis

Interventions

Case series:Nil

Sponsors

Department of Cardiology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who are older than 18 years old and underwent TAVR procedures at the included TAVR centers since December 1st, 2019. Inclusion lasts consecutively for 60 months.

Exclusion criteria

Exclusion criteria: Patients enrolled in other clinical trials with undisclosed clinical data

Design outcomes

Primary

MeasureTime frame
all-cause mortality within 1 year of TAVR procedure;—

Countries

China

Contacts

Public ContactMao Chen

Department of Cardiology, West China Hospital, Sichuan University

hmaochen@vip.sina.com+86 18980602046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026